nach oben

Die Ophthalmologie

Erschienen in:

21.04.2021 | Übersichten

Risk factors for open-angle glaucoma and recommendations for glaucoma screening

verfasst von: Univ.-Prof. Dr. med. Alexander K. Schuster, Felix M. Wagner, Norbert Pfeiffer, Esther M. Hoffmann

Erschienen in: Die Ophthalmologie | Sonderheft 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Open-angle glaucomas are a group of chronic progressive optic nerve neuropathies with a gonioscopic open anterior chamber angle. They are one of the main causes of visual impairment and blindness in industrialized countries. The aim of this article is to discuss and evaluate the epidemiology and risk factors for the development of open-angle glaucoma and to present the screening procedure for open-angle glaucoma according to the recently published S2e guidelines of the Association of the Scientific Medical Societies in Germany (AWMF).

European Glaucoma Society (2014) Terminology and guidelines for glaucoma, 4 edn. PubliComm, Savona

Crabb DP, Smith ND, Glen FC et al (2013) How does glaucoma look?: patient perception of visual field loss. Ophthalmology 120:1120–1126 PubMedCrossRef

Weih LM, Nanjan M, Mccarty CA et al (2001) Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology 108:1966–1972 PubMedCrossRef

Garway-Heath DF, Crabb DP, Bunce C et al (2015) Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet 385:1295–1304 PubMedCrossRef

Leske MC, Heijl A, Hussein M et al (2003) Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 121:48–56 PubMedCrossRef

Leske MC, Heijl A, Hyman L et al (2007) Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114:1965–1972 PubMedCrossRef

Deutsche Ophthalmologische Gesellschaft (2020) Deutsche Ophthalmologische Gesellschaft (DOG), Berufsverband der Augenärzte Deutschlands e. V. BVA, Bewertung von Risikofaktoren für das Auftreten des Offenwinkelglaukoms. Leitlinie von DOG und BVA. Ophthalmologe https://doi.org/10.1007/s00347-020-01169-4 CrossRef

Tham YC, Li X, Wong TY et al (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121:2081–2090 PubMedCrossRef

Hohn R, Nickels S, Schuster AK et al (2018) Prevalence of glaucoma in Germany: results from the Gutenberg Health Study. Graefes Arch Clin Exp Ophthalmol 256:1695–1702 PubMedCrossRef

10.

Kapetanakis VV, Chan MP, Foster PJ et al (2016) Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol 100:86–93 PubMedCrossRef

11.

Astrom S, Stenlund H, Linden C (2007) Incidence and prevalence of pseudoexfoliations and open-angle glaucoma in northern Sweden: II. Results after 21 years of follow-up. Acta Ophthalmol Scand 85:832–837 PubMedCrossRef

12.

Cedrone C, Mancino R, Ricci F et al (2012) The 12-year incidence of glaucoma and glaucoma-related visual field loss in Italy: the Ponza eye study. J Glaucoma 21:1–6 PubMedCrossRef

13.

Czudowska MA, Ramdas WD, Wolfs RC et al (2010) Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study. Ophthalmology 117:1705–1712 PubMedCrossRef

14.

De Voogd S, Ikram MK, Wolfs RC et al (2005) Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study. Ophthalmology 112:1487–1493 PubMedCrossRef

15.

Hitzl W, Stollinger M, Grabner G et al (2006) The Salzburg-Moorfields Collaborative Glaucoma Study: first results of the prevalence and 5‑year incidences in this prospective, population-based longitudinal study. Klin Monatsbl Augenheilkd 223:970–973 PubMedCrossRef

16.

Kawasaki R, Wang JJ, Rochtchina E et al (2013) Retinal vessel caliber is associated with the 10-year incidence of glaucoma: the Blue Mountains Eye Study. Ophthalmology 120:84–90 PubMedCrossRef

17.

Mukesh BN, Mccarty CA, Rait JL et al (2002) Five-year incidence of open-angle glaucoma: the visual impairment project. Ophthalmology 109:1047–1051 PubMedCrossRef

18.

Leske MC, Wu SY, Honkanen R et al (2007) Nine-year incidence of open-angle glaucoma in the Barbados Eye Studies. Ophthalmology 114:1058–1064 PubMedCrossRef

19.

Pan CW, Yang WY, Hu DN et al (2017) Longitudinal cohort study on the incidence of primary open-angle glaucoma in Bai Chinese. Am J Ophthalmol 176:127–133 PubMedCrossRef

20.

Varma R, Wang D, Wu C et al (2012) Four-year incidence of open-angle glaucoma and ocular hypertension: the Los Angeles Latino Eye Study. Am J Ophthalmol 154:315–325.e311 PubMedPubMedCentralCrossRef

21.

Vijaya L, Rashima A, Panday M et al (2014) Predictors for incidence of primary open-angle glaucoma in a South Indian population: the Chennai eye disease incidence study. Ophthalmology 121:1370–1376 PubMedCrossRef

22.

Ramdas WD, Wolfs RC, Hofman A et al (2011) Ocular perfusion pressure and the incidence of glaucoma: real effect or artifact? The Rotterdam Study. Invest Ophthalmol Vis Sci 52:6875–6881 PubMedCrossRef

23.

Le A, Mukesh BN, Mccarty CA et al (2003) Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci 44:3783–3789 PubMedCrossRef

24.

Ekstrom C (2012) Risk factors for incident open-angle glaucoma: a population-based 20-year follow-up study. Acta Ophthalmol 90:316–321 PubMedCrossRef

25.

Mitchell P, Rochtchina E, Lee AJ et al (2002) Bias in self-reported family history and relationship to glaucoma: the Blue Mountains Eye Study. Ophthalmic Epidemiol 9:333–345 PubMedCrossRef

26.

Kass MA, Heuer DK, Higginbotham EJ et al (2002) The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701–713 (discussion 829–730) PubMedCrossRef

27.

Miglior S, Zeyen T, Pfeiffer N et al (2005) Results of the European Glaucoma Prevention Study. Ophthalmology 112:366–375 PubMedCrossRef

28.

Cook JA, Botello AP, Elders A et al (2012) Systematic review of the agreement of tonometers with Goldmann applanation tonometry. Ophthalmology 119:1552–1557 PubMedCrossRef

29.

Miglior S, Pfeiffer N, Torri V et al (2007) Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 114:3–9 PubMedCrossRef

30.

Reiter C, Gramer E, Gramer G (2012) Pseudoexfoliation syndrome: no central zone of pseudoexfoliation material in patients with pseudophakia—a clinical study. Klin Monatsbl Augenheilkd 229:241–245 PubMedCrossRef

31.

Siddiqui Y, Ten Hulzen RD, Cameron JD et al (2003) What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol 135:794–799 PubMedCrossRef

32.

Marcus MW, Muskens RP, Ramdas WD et al (2012) Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study. Drugs Aging 29:963–970 PubMedCrossRef

33.

Alfano JE (1963) Changes in the intraocular pressure associated with systemic steroid therapy. Am J Ophthalmol 56:245–247 PubMedCrossRef

34.

Armaly MF (1963) Effect of corticosteroids on Intraocular pressure and fluid dynamics. I. The effect of dexamethasone in the normal eye. Arch Ophthalmol 70:482–491 PubMedCrossRef

35.

Bernstein HN, Schwartz B (1962) Effects of long-term systemic steroids on ocular pressure and tonographic values. Arch Ophthalmol 68:742–753 PubMedCrossRef

36.

Ahmadi N, Snidvongs K, Kalish L et al (2015) Intranasal corticosteroids do not affect intraocular pressure or lens opacity: a systematic review of controlled trials. Rhinology 53:290–302 PubMedCrossRef

37.

Valenzuela CV, Liu JC, Vila PM et al (2019) Intranasal corticosteroids do not lead to ocular changes: a systematic review and meta-analysis. Laryngoscope 129:6–12 PubMedCrossRef

38.

Mitchell P, Cumming RG, Mackey DA (1999) Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology 106:2301–2306 PubMedCrossRef

39.

Becker B, Mills DW (1963) Corticosteroids and intraocular pressure. Arch Ophthalmol 70:500–507 PubMedCrossRef

40.

Chang DF, Tan JJ, Tripodis Y (2011) Risk factors for steroid response among cataract patients. J Cataract Refract Surg 37:675–681 PubMedCrossRef

41.

Kiddee W, Trope GE, Sheng L et al (2013) Intraocular pressure monitoring post intravitreal steroids: a systematic review. Surv Ophthalmol 58:291–310 PubMedCrossRef

42.

Augustin AJ, Bopp S, Fechner M et al (2020) Three-year results from the retro-IDEAL study: real-world data from diabetic macular edema (DME) patients treated with ILUVIEN(®) (0.19 mg fluocinolone acetonide implant). Eur J Ophthalmol 30:382–391 PubMedCrossRef

43.

Hollands H, Johnson D, Hollands S et al (2013) Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review. JAMA 309:2035–2042 PubMedCrossRef

44.

Crowston JG, Hopley CR, Healey PR et al (2004) The effect of optic disc diameter on vertical cup to disc ratio percentiles in a population based cohort: the Blue Mountains Eye Study. Br J Ophthalmol 88:766–770 PubMedPubMedCentralCrossRef

45.

Gupta P, Zhao D, Guallar E et al (2016) Prevalence of Glaucoma in the United States: The 2005–2008 National Health and Nutrition Examination Survey. Invest Ophthalmol Vis Sci 57:2905–2913 PubMedCrossRef

46.

Kim KE, Park KH (2017) Optic disc hemorrhage in glaucoma: pathophysiology and prognostic significance. Curr Opin Ophthalmol 28:105–112 PubMedCrossRef

47.

Deva NC, Insull E, Gamble G et al (2008) Risk factors for first presentation of glaucoma with significant visual field loss. Clin Exp Ophthalmol 36:217–221 PubMedCrossRef

48.

Li T, Lindsley K, Rouse B et al (2016) Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis. Ophthalmology 123:129–140 PubMedCrossRef

49.

Chan MPY, Broadway DC, Khawaja AP et al (2017) Glaucoma and intraocular pressure in EPIC-Norfolk Eye Study: cross sectional study. BMJ 358:j3889 PubMedPubMedCentralCrossRef

50.

Vessani RM, Moritz R, Batis L et al (2009) Comparison of quantitative imaging devices and subjective optic nerve head assessment by general ophthalmologists to differentiate normal from glaucomatous eyes. J Glaucoma 18:253–261 PubMedCrossRef

51.

Abrams LS, Scott IU, Spaeth GL et al (1994) Agreement among optometrists, ophthalmologists, and residents in evaluating the optic disc for glaucoma. Ophthalmology 101:1662–1667 PubMedCrossRef

52.

Wang F, Tielsch JM, Ford DE et al (1998) Evaluation of screening schemes for eye disease in a primary care setting. Ophthalmic Epidemiol 5:69–82 PubMedCrossRef

53.

Katz J, Sommer A (1990) Screening for glaucomatous visual field loss. The effect of patient reliability. Ophthalmology 97:1032–1037 PubMedCrossRef

54.

Michelessi M, Li T, Miele A et al (2020) Accuracy of optical coherence tomography for diagnosing glaucoma: an overview of systematic reviews. Br J Ophthalmol. https://doi.org/10.1136/bjophthalmol-2020-316152 CrossRefPubMed

55.

Liu H, Li L, Wormstone IM et al (2019) Development and validation of a deep learning system to detect glaucomatous optic neuropathy using fundus photographs. JAMA Ophthalmol 137:1353–1360 PubMedPubMedCentralCrossRef

56.

Tuck MW, Crick RP (1997) The cost-effectiveness of various modes of screening for primary open angle glaucoma. Ophthalmic Epidemiol 4:3–17 PubMedCrossRef

57.

Iyer JV, Boland MV, Jefferys J et al (2020) Defining glaucomatous optic neuropathy using objective criteria from structural and functional testing. Br J Ophthalmol. https://doi.org/10.1136/bjophthalmol-2020-316237 CrossRefPubMed

58.

Rotchford AP, Uppal S, Lakshmanan A et al (2012) Day-to-day variability in intraocular pressure in glaucoma and ocular hypertension. Br J Ophthalmol 96:967–970 PubMedCrossRef

59.

Gramer G, Gramer E (2018) Stage of visual field loss and age at diagnosis in 1988 patients with different glaucomas: implications for glaucoma screening and driving ability. Int Ophthalmol 38:429–441 PubMedCrossRef

Titel: Risk factors for open-angle glaucoma and recommendations for glaucoma screening
verfasst von: Univ.-Prof. Dr. med. Alexander K. Schuster
Felix M. Wagner
Norbert Pfeiffer
Esther M. Hoffmann
Publikationsdatum: 21.04.2021
Verlag: Springer Medizin
Erschienen in: Die Ophthalmologie / Ausgabe Sonderheft 2/2021
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI: https://doi.org/10.1007/s00347-021-01378-5

Neu im Fachgebiet Augenheilkunde

02.03.2023 | Basalzellkarzinom | Leitthema

Hauptrubriken

Service

Fachgebiete

Themen

Sammlungen

Springer Medizin

Risk factors for open-angle glaucoma and recommendations for glaucoma screening

Abstract

Neu im Fachgebiet Augenheilkunde

Chirurgische Exzision von Lidtumoren und anschließende ophthalmoplastische Rekonstruktionen

Glaukom im Säuglings- und Kindesalter

SOP-Lidtumoren

Diagnose und Therapie der benignen Lidtumoren

Hauptrubriken

Service

Fachgebiete

Themen

Sammlungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 2/2021

The urgency of surgical treatment for rhegmatogenous retinal detachment

Statement of the German Ophthalmological Society (DOG), the Retinological Society (RG) and the Professional Association of Ophthalmologists in Germany (BVA) on the timing of treatment of rhegmatogenous retinal detachment

Erratum zu: Aktuelle Glaukomchirurgie

Erratum zu: Pterygium: Pathogenese, Diagnose und Therapie

Erratum zu: Plötzliche bilaterale Visusminderung und Gesichtsfeldausfälle

Akute Verätzung am Auge

Neu im Fachgebiet Augenheilkunde

Chirurgische Exzision von Lidtumoren und anschließende ophthalmoplastische Rekonstruktionen

Glaukom im Säuglings- und Kindesalter

SOP-Lidtumoren

Diagnose und Therapie der benignen Lidtumoren